Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. Viewhere

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHD.L Regulatory News (PHD)

  • There is currently no data for PHD

Director/PDMR Shareholding

22 Jun 2010 16:31

RNS Number : 0630O
PROACTIS Holdings PLC
22 June 2010
 



22 June 2010

 

PROACTIS Holdings PLC

 

("Proactis" or "the Company")

 

Director/PDMR Shareholding

 

PROACTIS Holdings PLC (LSE: PHD) ("Proactis" or the "Company" or "Group") announces that it has received notification from its Chairman, Alan Aubrey, that, on 21 June 2010, 728,307 Ordinary shares of 10p each ("Ordinary Shares") were transferred from his own name to the Alan John Aubrey 2010 Settlement, a trust in which Alan Aubrey is the sole beneficiary.

Following this transaction, Alan Aubrey's beneficial interest in the Company remains unchanged at 945,853 Ordinary Shares, representing 3.04% of the Company's issued share capital.

 

For further information, please contact:

 

PROACTIS Holdings PLC

Tim Sykes, Chief Financial Officer Tel: 019 3754 5070

www.proactis.com

 

Daniel Stewart & Company plc

Simon Leathers / Emma Earl Tel: 020 7776 6550

www.danielstewart.co.uk

 

 

 

Notes to Editors:

 

Proactis creates, sells and maintains specialist software, which enables organisations to streamline, control and monitor all internal and external expenditure, other than payroll. PROACTIS is already used in over 300 organisations in the UK from the commercial, public and not-for-profit sectors.

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSSEFFIEFSSEDM
Date   Source Headline
17th Nov 20149:28 amRNSIssue of Equity
4th Nov 20148:30 amRNSIssue of Equity
22nd Oct 20147:00 amRNSIssue of Equity
21st Oct 20149:23 amRNSIssue of Equity
6th Oct 20147:00 amRNSPreliminary Results
30th Sep 20147:00 amRNSNotice of Results
4th Sep 20141:11 pmRNSHolding(s) in Company
29th Aug 20144:22 pmRNSHolding(s) in Company
26th Aug 201411:35 amRNSIssue of equity
20th Aug 201410:00 amRNSTotal Voting Rights
19th Aug 20144:17 pmRNSHolding(s) in Company
19th Aug 201411:57 amRNSHolding(s) in Company
12th Aug 20147:00 amRNSTrading Update
7th Aug 20149:00 amRNSHolding(s) in Company
5th Aug 20147:00 amRNSSale of Treasury Shares
4th Aug 20147:00 amRNSAcquisition of Intelligent Capture Limited
30th Jul 20147:00 amRNSIssue of Equity
27th Jun 201412:53 pmRNSHolding(s) in Company
27th Jun 201411:22 amRNSHolding(s) in Company
25th Jun 20147:00 amRNSPROACTIS Signs Landmark Procurement Contract in US
3rd Jun 20147:00 amRNSAwarded GCloud V Framework Agreement
3rd Jun 20147:00 amRNSCompletion of acquisition
16th May 201412:12 pmRNSHolding(s) in Company
15th May 201410:00 amRNSHolding(s) in Company
13th May 20147:00 amRNSIssue of Equity
8th May 20147:00 amRNSIssue of Equity
29th Apr 20142:59 pmRNSDirectors' Subscription
29th Apr 20147:00 amRNSAcquisition of Intesource Inc
14th Apr 201412:15 pmRNSResult of General Meeting
4th Apr 20147:00 amRNSIssue of equity
31st Mar 20147:00 amRNSNotice of General Meeting
27th Mar 20141:17 pmRNSHolding(s) in Company
18th Mar 20147:00 amRNSPlacing to raise £2.2 million
3rd Mar 20147:00 amRNSInterim Results
19th Feb 20147:00 amRNSTrading Update
17th Feb 20147:00 amRNSIssue of Equity
10th Feb 20147:00 amRNSCompletion of acquisition
20th Jan 20143:12 pmRNSIssue of Equity
16th Jan 20142:02 pmRNSGrant of options to Directors
14th Jan 20147:00 amRNSAcquisition of EGS Group Limited
16th Dec 201312:22 pmRNSResult of AGM
12th Dec 20137:00 amRNSIssue of Equity
5th Dec 201310:02 amRNSHolding(s) in Company
13th Nov 20139:57 amRNSHolding(s) in Company
13th Nov 20138:38 amRNSHolding(s) in Company
2nd Oct 20137:00 amRNSPreliminary Results
12th Aug 20137:00 amRNSTrading Update
9th May 20137:00 amRNSLaunch of New eProcurement App
15th Apr 20137:00 amRNSDutch higher education platform extended
10th Apr 20137:00 amRNS3 Year Contract with Global Financial Institution

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.